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Vagal nerve stimulation is an emerging therapy for epilepsy, yet little is known regarding the effects of this stimulation on 
heart period variability. We selected 10 patients (two female, eight male) who were receiving high-frequency, high-intensity 
left vagal nerve stimulation for intractable epilepsy. Electrocardiogram data were recorded for a 7 min baseline, 2.5 min 
of stimulation and a 7 min post-stimulation period. We found no significant changes in average heart period, instantaneous 
changes of successive R-to-R intervals greater than 50 ms or fractal dimension. We also found no significant changes in the 
total power in the 0.0-0.04 Hz, 0.04-0.12 Hz and 0.2-0.4 Hz bands with stimulation of the left vagus nerve. This study 
suggests that left vagal nerve stimulation has little acute effect on the cardiac rhythm or heart period variability. 
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epilepsy. 
INTRODUCTION 
Direct vagal nerve stimulation (VNS) has emerged 
as a treatment for intractable epilepsy. Studies have 
shown a reduction in seizure frequency with high- 
frequency (HF) (typically 30 Hz) stimulation of the 
left vagus nerve at maximum tolerable intensity (high 
intensity)‘. The left vagus nerve was chosen because 
it has minimal direct cardiac efferent activity*. 
Traditional methods of evaluating cardiac func- 
tions during VNS have been inconclusive. The vagus 
nerve contains 10% efferent fibres which innervate 
the stomach, intestines, lungs and heart3. The input 
from the left vagus nerve has a minimal effect on 
the atrioventricular node and no influence over the 
sinoatrial node4. Kolman5, studying dogs, reported 
that VNS produced a change in the repolarization of 
the canine ventricle. Holder ef al’ and Uthman er af* 
found that left vagal stimulation in humans produced 
no significant changes in heart rate. Ramsay found 
no effect on cardiac function after ambulatory Holter 
monitoring. Kamath et ati studied heart rate variabil- 
ity in patients implanted with vagal nerve stimulators 
at two stimulation frequencies and found that in four 
patients the high-frequency, high-intensity setting re- 
sulted in a significant increase in the 0.2-0.5 Hz fre- 
quency band of the power spectrum4. 
The autonomic nervous system and neurohumoral 
influences modulate heart rate7. Heart period vari- 
ability (HPV) is a sensitive, noninvasive method of 
quantifying dynamic autonomic influences over the 
heart period. Many studi.es have documented the 
variation of heart rate on a beat-to-beat basis in 
patients with obstructive sleep apnoea, Alzheimer’s 
disease, Parkinson’s disease, epilepsy and sleep 
states8-I’. Beat-to-beat variations quantified by the 
contributions of each frequency band gives clues 
to these influences7y’3-‘6. The low-frequency band 
(0.00-0.04 Hz) is related to neurohumoral and ther- 
mal regulatory influences and is increased with an- 
giotensin converting enzyme inhibitors’3* 16. The mid- 
frequency band (0.04-0.12 Hz) is related to a mix- 
ture of sympathetic and parasympathetic influences 
and can be partially blocked by propranolol. The HF 
band (0.2-0.4 Hz) is principally related to respiration 
utilizing vagal mediated pathways and can be blocked 
by at.ropine13* 16-t8. 
Since increased power in the HF band of the power 
spectra is related to parasympathetic input, we felt 
that analysis of the HPV would be a valuable tool for 
studying the effect of left VNS on the cardiac cycle. 
MATERIALS AND METHODS 
Ten patients (two female, eight male) with intractable 
epilepsy who have been instrumented with left 
vagoafferent electrical stimulators (Cyberonics Model 
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100 (Cybertronics, Inc., Webster, Texas, USA)) were 
selected for study. All of these patients were part of 
the open-label continuation study (Cyberonics XE5 
protocol) with vagal stimulator settings of 30 Hz, 
pulse width of 750 ps, on-time of 30 s, and off-time 
of 5 min. Current was set at the maximum tolera- 
ble level (a high-intensity setting) for a minimum of 
1 month prior to our study. 
For this study additional data were collected which 
were separate from the Cyberonics XE5 protocol de- 
scribed above. During data collection for heart period 
analysis, patients were awake, in the supine position, 
and asked not to speak. A 7 min baseline segment was 
recorded with the vagal nerve stimulator inactivated. 
The stimulator was then activated for five sequential 
30 s stimulation periods for a total continuous stim- 
ulation period of 2.5 min. Stimulation was verified 
by the subject noting the presence of the sensation 
of stimulation. Following the stimulation period, the 
vagal nerve stimulator was inactivated for a 7 min 
post-stimulation period. 
The EKG was amplified, displayed and digitized at 
500 Hz. The peak of each QRS complex was iden- 
tified and the sequential R-to-R intervals were cal- 
culated. The digitized EKG was reviewed off-line 
to ensure that no beats were improperly marked, no 
beats were missed, and no artifacts were detected as 
R waves. The time domain data were presented on 
the computer graphics screen for visual verification 
prior to analysis’Z.20,“. 
The data were divided into baseline, stimulation 
and post-stimulation data sets for each patient. For 
each data set, the mean and standard deviation of the 
heart period, fractal dimension and the average num- 
ber of beat-to-beat variations which exceeded 50 ms 
(BB50) per 128 R-to-R intervals were calculated. The 
heart period was defined as the time between two con- 
secutive QRS waves. The BB50 was defined as the 
number of R-to-R intervals that have a greater than 
50 ms change from the previous interval for each 128 
beat epoch. The 128 interval epochs were chosen for 
this calculation to equate the unequal time periods of 
prestimulation, stimulation and post-stimulation. The 
fractal dimension provides a concise way to express 
the complexity of the variation in the heart period. 
The fractal dimension was calculated as a ratio of the 
sum of the distance between all data points in the 
period or epoch divided by the distance between the 
first and the most distant data point. The time domain 
data were essential for proper interpretation of the fre- 
quency domain analysis and was required to avoid in- 
cluding nonstationary data in the frequency analysis. 
For each data set, the R-to-R intervals were divided 
into sequential 128 R-to-R interval epochs. Each data 
set from each patient was averaged together to derive 
the average power in each of three frequency bands 
for the baseline, stimulation and post-stimulation peri- 
ods. The three frequency bands were 0.0-0.04, 0.04- 
0.12 and 0.2-0.4 Hz. Since the spectral power of 
a set of data is proportional to the variance of the 
data in the time domain, the average power in these 
frequency bands was used for statistical purposes to 
determine the significance of changes in HPV. The 
units of power for HPV are s’/s2/Hz. The same 
calculations were performed on all frequency bands. 
The F test for equal variances was used as a mea- 
sure of the significance between the three data sets in 
each individual. Changes at the 0.05 level, using two 
tails, were considered to be significant for each time 
period”. Repeated measures univariate analysis of 
variance with the dependent variables of HPV, BB50, 
FD and the three frequency bands of 0.0-0.04, 0.04 
0.12 and 0.2-0.4 were calculated across the three 
measurement points of baseline, stimulation and post- 
stimulation. An alpha level of 0.01 was chosen to re- 
duce error as multiple comparisons were completed. 
The relationship between clinical effectiveness (de- 
fined as a reduction in seizure frequency of 50%) and 
HPV changes were analysed using Student’s t-test. 
Additionally, HPV changes from patients with maxi- 
mum tolerable current settings of 2.0 mA or greater 
were compared with those with output currents of less 
than 2.0 mA using Student’s r-test. 
RESULTS 
Ten subjects, aged 14-46 (average 28 years; eight 
male, two female) were diagnosed with intractable 
complex partial epilepsy defined as failure to respond 
to three or more conventional anticonvulsants. All pa- 
tients averaged six or more seizures per month and 
were receiving anticonvulsant therapy. None of the 
patients had undergone cerebral surgery. One patient 
had a history of head trauma as the presumed aeti- 
ology for epilepsy. The remaining nine did not have 
definable aetiologies for their seizures. 
Time domain 
The average heart period of the 10 subjects did 
not change significantly during stimulation or post- 
stimulation periods when compared with the prestim- 
ulation period (Table 1). The results of the BB50 and 
fractal dimension analysis did not reveal any signif- 
icant changes either. Finally, visual analysis of the 
time domain was without apparent changes (Fig. 1). 
Repeated measures analysis of variance for the aver- 
age heart period, BB50 and fractal dimension were 
all nonsignificant. 
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Table 1: Time domain results 
Heart period (s) 
Baseline 
0.728 
SD 
0.097 
Stimulation 
0.7 133 
SD 
0.086 
Post stimulation 
0.726 
SD 
0.093 
BB50 (instantaneous 
beat-to-beat changes greater 
than 50 ms/l28 intervals) 
6.15 6.77 4.45 4.43 4.47 6.7 I 
Fractal dimension I .67 0.331 I .66 0.253 I .66 0.269 
R/R intervals 
Fig. 1: Time domain depicting heart period vs. successive R-to-R intervals before, during and after VNS in one patient. The figure 
shows a decrease in the HF variation of heart period during stimulation. Ttiis observed change was not statistically significant 
among the 10 patients in this study. 
Frequency domain 
The power in each of the frequency bands showed 
no significant changes during or after direct left VNS 
when compared with the baseline (Table 2). Repeated 
measures analysis of variance found no significant 
differences across time from the baseline, stimulation 
and post-stimulation periods. The average power in 
the 0.0-0.4 Hz band appeared to increase in the post- 
stimulation period. This increase was not statistically 
significant and the majority of the increase was re- 
lated to one patient (subject number 1 in Fig. 2). 
A trend towards decreased total power in the HF 
band during stimulation occurred in four out of 10 
patients. The decrease in total power in these four 
patients could not be accounted for by a shift in peak 
frequency or a move of power to another frequency 
band. Results were mixed for the remaining six pa- 
tients. The overall decrease in power in the HF band 
was not significant (baseline to stimulation p = 0.61, 
baseline to post-stimulation p = 0.30). In only one 
patient (patient number 3 in Fig. 2), power in the HF 
band was increased during and after stimulation. 
In addition, there was no relationship- between 
clinical effectiveness after VNS (defined as a greater 
than 50% reduction in seizure frequency) and HPV 
changes. Considering the threshold activation cur- 
rents suggested by Woodbury25, we decided to look 
at the relationship between current intensity at max- 
imum tolerable stimulation and HPV changes. We 
compared the HPV changes of patients whose maxi- 
mum tolerable current settings were 2.0 mA or greater 
with those whose settings were below 2:0 mA. We 
found no relationship between stimulation settings 
and changes in power in the various frequency bands. 
DISCUSSION 
HPV is an excellent tool for assessing the 
neurohumoral and autonomic influences over the 
cardiac cycle. Previous studies have used indirect 
methods to assess the vagal effects. upon HPV. At- 
ropine has been shown to attenuate the HF compo- 
nent of HPV’3*‘6*‘8*‘9. Studies on dogs have shown 
that vagotomy also decreases the HF component15. 
Our research differs from those studies in that we 
are directly stimulating only the left vagus nerve 
which innervates. the atrioventricular node and has 
significantly less effect on heart rate than bilateral 
stimulation4. 
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Table 2: Frequency domain results 
Baseline SD Stimulation SD Post stimulation SD 
0.0-0.04 Hz band (s2/sz/Hz) 1 .I7 1.82 2.69 2.21 3.68 5.65 
0.04-0.12 Hz band (s’/s*/Hz) 1.23 1.25 1.93 2.01 I .95 2.02 
0.2-0.4 Hz band (s2/s2/Hz) 0.805 0.089 0.62 1 0.541 0.779 1.23 
Baseline Stim Post-Stim 
Fig. 2: Total power in each frequency band for each of the 10 patients separated into baseline, stimulation and post-stimulation 
data sets on the x-axis. The y-axis is power (s2/s2/Hz), the z-axis is the patient number. The power values for patient number 
one post stimulation in the low-frequency band (0.0-0.04 Hz) is actually 13.3 s*/s*/Hz but is reduced to demonstrate the 
relationships between the other power values. 
This study shows that direct stimulation of the left 
vagus nerve has no significant effect on the HPV. 
We found no significant change in the HF band af- 
ter HF left VNS. This finding is consistent with cur- 
rent knowledge of anatomic pathways for the left va- 
gus nerve as well as the clinical findings of other 
researchers2y5. This is, however, in contrast to the 
findings of increased power in the HP band by Ka- 
math et ap. All of our patients were stimulated for 
at least 1 month at the tested settings, and therefore 
some accommodation to the stimulation not observed 
in the Kamath study may have occurred. Addition- 
ally, the difference may be related to differences in 
stimulation settings (pulse width 750 pus in our study 
versus 500 ,us in the Kamath study) which may se- 
lectively activate different efferent fibre types. Due to 
mixed reports in the literature, the precise cardiode- 
pressor vagal fibre type is not clearly known. The ev- 
idence indicates that a mixture of B and C fibre types 
innervate the heart22-24. Results from Woodbury and 
Woodbury suggest the settings used in this study 
may activate a larger number of vagal C fibre types 
than stimulated in the Kamath study. 
Kamath found an increase in HF power after VNS 
without a change in heart rate and speculated the ex- 
istence of a feedback loop through vagoafferent path- 
ways which would stimulate the heart without causing 
bradycardia4. Although four of our subjects had an in- 
crease in power in the HP band with stimulation, we 
found no statistically significant change in heart rate 
or the power of any frequency bands during stimula- 
tion for the group of 10 subjects. While the feedback 
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loop may exist, our results suggest that there are no 
significant changes in HPV to demonstrate that this 
loop influences the cardiac cycle through other fre- 
quency bands. 
Anticonvulsants may alter autonomic responses. 
All patients in the study remained on their anticon- 
vulsant therapy. Two patients were treated with carba- 
mazepine, which is known to have an anticholinergic 
effect, and may have masked any cholinergic changes 
due to VNS. These two patients had mixed changes 
of HPV. The other eight patients in the study were 
not using any medication with a known significant 
anticholinergic effect. Finally, we did not find any 
relationship between clinical effectiveness and stim- 
ulation intensity in terms of VNS and HPV changes. 
Future studies with more patients will be needed to 
address these issues. 
CONCLUSIONS 
Given the potential for VNS as a therapy for in- 
tractable epilepsy this study suggests that left VNS 
has little acute effect on the cardiac rhythm or HPV. 
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